Food and Drug Administration

GLP-1 drugs: clinical trends, safety, and market shifts

311 clusters · 1155 sources · last updated 1 day ago

Latest: GLP-1 receptor agonists linked to weight loss in peritoneal dialysis patients

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health, with some scientists suggest

Alzheimer's research: Detection, trials, and efficacy debate

24 clusters · 91 sources · last updated 1 day ago

Latest: Researchers identify new therapeutic pathways for Alzheimer's disease

Research into Alzheimer’s disease continues to evolve, focusing on early detection, molecular mapping, and the physiological breadth of the condition. While previous efforts emphasized biomarkers and AI-driven diagnostic

Radical Numerics AI-designed phage therapy administration

2 clusters · 14 sources · last updated 1 day ago

Latest: Radical Numerics claims AI-designed phage treatment for patient

The US-based startup Radical Numerics has reported the administration of an AI-designed bacteriophage cocktail to a human patient suffering from a multi-drug resistant bacterial infection. The treatment was conducted und

Global peptide research and regulatory developments

5 clusters · 21 sources · last updated 1 day ago

Latest: Health officials consider policy shifts regarding synthetic peptides

Peptides are seeing increased interest across medical, wellness, and skincare sectors, driven by scientific research into longevity and the popularity of GLP-1 medications. In the United States, an FDA advisory committee

Maharashtra drought impact on sugarcane production

3 clusters · 5 sources · last updated 1 day ago

Latest: Maharashtra farmers protest over drought and sugarcane payments

The 2026-27 sugarcane crushing season has commenced in Maharashtra, with 55 mills already operational as of mid-October. Despite an increase in total cultivation area, industry experts warn of a 20% to 25% decline in sug

Iran pharmaceutical crisis: supply chain and rising costs

19 clusters · 23 sources · last updated 1 day ago

Latest: Iran Health Insurance Organization faces funding shortages and debt accumulation

Iran continues to face severe financial and liquidity pressures affecting its pharmaceutical sector. While total essential drug shortages decreased from 341 items in 2022 to approximately 65 in recent months, recent repo

Health risks of vitamin deficiency and supplementation

19 clusters · 46 sources · last updated 1 day ago

Latest: Medical expert warns against excessive vitamin supplementation

Medical experts continue to warn against the unregulated use of dietary supplements, emphasizing that ‘natural’ products can pose significant health risks. Recent scrutiny has focused on Vitamin D quality and dosage. A s

FDA toothpaste recall by Pritam International

2 clusters · 15 sources · last updated 2 days ago

Latest: FDA recalls 4.3 million tubes of toothpaste due to manufacturing violations

The U.S. Food and Drug Administration (FDA) issued a Class II recall for approximately 4.3 million tubes of fluoride toothpaste. The voluntary recall was initiated by Pritam International Private Limited, an Indiana-base

Research on NAD+ precursors and metabolic health

2 clusters · 3 sources · last updated 2 days ago

Latest: Mitochondrial function and NAD+ precursors linked to aging and metabolic health

Discussions regarding Nicotinamide mononucleotide (NMN) and NAD+ precursors have focused on their role in cellular energy production and metabolism. Early reports highlight NMN as a precursor molecule used to support ene

Expanding therapeutic uses and regulatory approvals for GLP-

33 clusters · 154 sources · last updated 3 days ago

Latest: GLP-1 medications show weight loss challenges regarding muscle mass and maintenance

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

US FDA experimental treatment access debate

2 clusters · 5 sources · last updated 3 days ago

Latest: FDA access to experimental cancer treatments debated

A debate has emerged regarding the rights of American patients to access experimental medical treatments before receiving full regulatory approval from the Food and Drug Administration (FDA). The discussion is centered

Adrenaline nasal spray developments for anaphylaxis

2 clusters · 16 sources · last updated 3 days ago

Latest: Italy approves adrenaline nasal spray for anaphylaxis treatment

Developments regarding adrenaline nasal sprays as an alternative to traditional auto-injectors for treating anaphylaxis have emerged in Europe. In Italy, the Italian Medicines Agency (AIFA) has approved the spray for us

RFK Jr. HHS leadership, vaccine policy & legal challenges

72 clusters · 320 sources · last updated 3 days ago

Latest: HHS Secretary RFK Jr. promotes nutritional education and discusses vaccine research

Since his April 2026 appointment, HHS Secretary Robert F. Kennedy Jr. has reshaped U.S. health governance, installing acting heads at the CDC, NIH, FDA and the Surgeon‑General’s office. He has issued rules on ultra‑proce

Respiratory virus vaccination guidance and developments

18 clusters · 67 sources · last updated 4 days ago

Latest: Ontario health officials urge vaccination as respiratory illness season begins

The respiratory virus vaccination season is underway across North America and globally, with a focus on influenza, COVID-19, and RSV. In the United States, Moderna’s mRNA-based mFLUSIVA is available for adults aged 50 an

AI healthcare integration expands amid privacy and cost

24 clusters · 107 sources · last updated 4 days ago

Latest: US healthcare groups urge FDA to hold AI developers accountable

Since the July 2026 summit, AI deployment in healthcare has accelerated toward a collaborative model, though integration is increasingly complicated by privacy, economic, and safety tensions. Clinicians are adopting too

US synthetic kratom investigation and fatalities

2 clusters · 11 sources · last updated 4 days ago

Latest: San Francisco reports first fatal overdose involving kratom-derived opioid

Authorities in several US states are investigating the distribution of potent, semi-synthetic kratom compounds following reports of fatalities. In Utah, health officials linked four deaths over a four-month period to mit

Kratom regulation and safety in the United States

7 clusters · 29 sources · last updated 5 days ago

Latest: Hillsborough County considers ban on potent kratom compound

Kratom occupies a complex regulatory position in the United States. While the FDA has not scheduled the botanical product, it has stated that no kratom-containing products are legally marketed as prescription drugs, over

FDA approves Rasonque; EMA recommends for pancreatic cancer

44 clusters · 321 sources · last updated 6 days ago

Latest: Pancreatic cancer: New research and treatment developments in Greece

On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R

US beef import tariffs and industry restructuring

27 clusters · 381 sources · last updated 6 days ago

Latest: US cattle ranchers report losses from Trump beef import policy

The suspension of out-of-quota tariffs on up to 300,000 metric tons of imported lean beef trimmings, which commenced on September 1, 2026, is being implemented in three 100,000-ton installments. Authorized by Proclamatio

Legal challenges involving Students for Life of America

2 clusters · 6 sources · last updated 6 days ago

Latest: Texas woman sues Students for Life over abortion pill advocacy

The advocacy group Students for Life of America (SFLA) has become involved in multiple legal disputes regarding abortion medication and policy. In September 2026, the group issued a notice of intent to sue the U.S. Food

Texas lawsuit against Nestlé and Gerber over baby food

2 clusters · 6 sources · last updated 8 days ago

Latest: Texas sues Nestlé and Gerber over heavy metals in baby food

Texas Attorney General Ken Paxton has filed a lawsuit against Gerber Products Company and its parent company, Nestlé USA, alleging the companies misled consumers regarding the safety of their baby food products under the

Lidl food product labeling and safety concerns

2 clusters · 4 sources · last updated 8 days ago

Latest: Lidl recalls Gelatelli coffee and vanilla gelato over Listeria concerns

Issues regarding Lidl food products have emerged concerning both ingredient transparency and safety. Initially, concerns were raised in France regarding the difficulty consumers face when identifying the specific origin

US federal marijuana rescheduling legal proceedings

2 clusters · 4 sources · last updated 9 days ago

Latest: DEA marijuana rescheduling process faces administrative delays

The federal process to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act has encountered administrative and legal delays. In late September 2026, Chief Administrative Law Judge Der

Maharashtra FDA Commissioner enforcement controversy

8 clusters · 32 sources · last updated 9 days ago

Latest: Maharashtra FDA seizes ₹48 lakh in expired food, suspends major warehouse licenses

Maharashtra Food and Drug Administration (FDA) Commissioner Tukaram Mundhe has faced internal and external scrutiny following his aggressive enforcement of food safety standards. Since taking office in May 2026, Mundhe h

FDA rare disease drug development reform

3 clusters · 10 sources · last updated 9 days ago

Latest: FDA launches initiative to standardize rare disease drug reviews

The U.S. Food and Drug Administration (FDA) has launched the ‘Rare Disease Framework Initiative’ to redesign the development and review process for drugs and biologics targeting rare conditions. The initiative seeks to m

MHRA regulatory strategy and international cooperation

2 clusters · 6 sources · last updated 12 days ago

Latest: MHRA unveils 2030 strategy focused on AI and patient safety

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has expanded its focus on international cooperation and future technological integration. In September 2026, the MHRA strengthened its regulatory partn

US medical equipment accessibility and Medicare regulation

2 clusters · 5 sources · last updated 12 days ago

Latest: Medical organizations comment on CMS RAPID coverage pathway

The United States has introduced new federal mandates to improve medical equipment accessibility for individuals with disabilities. Under the Rehabilitation Act and the Americans with Disabilities Act, the Department of

US psychedelic therapy regulatory and research developments

5 clusters · 12 sources · last updated 12 days ago

Latest: FDA holds hearing on regulatory future of psychedelic therapies

The U.S. Food and Drug Administration (FDA) is working to develop a new framework to accelerate patient access to psychedelic medicines, such as psilocybin and DMT, to address the national mental health crisis. During a

US animal welfare and testing policy updates

3 clusters · 11 sources · last updated 12 days ago

Latest: Trump administration proposes new animal welfare standards

The U.S. Department of Agriculture (USDA) and the Department of Health and Human Services (HHS) have launched initiatives to enhance oversight and welfare for companion animals and reduce reliance on animal testing. In

US legislative efforts regarding mifepristone

2 clusters · 4 sources · last updated 13 days ago

Latest: U.S. lawmakers demand FDA updates on mifepristone safety study

In late September 2026, Senator Josh Hawley introduced the ‘Safeguarding Women from Chemical Abortion Act,’ calling for a congressional ban on the abortion medication mifepristone. Hawley argued the drug is unsafe for bo